Related Experiment Video
Updated: Oct 3, 2025

17:16
Registered Bioimaging of Nanomaterials for Diagnostic and Therapeutic Monitoring
Published on: December 9, 2010
10.4K
Quantification and 3D Localization of Magnetically Navigated Superparamagnetic Particles Using MRI in Phantom and
IEEE Transactions on Bio-Medical Engineering
|February 15, 2022
Summary
Magnetic drug-eluting beads (MDEBs) were accurately quantified and localized using 3D VIBE MRI sequences. This method enables precise tracking of SPIONs for targeted cancer therapy delivery.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Medical Imaging
Background:
- Superparamagnetic iron oxide nanoparticles (SPIONs) are utilized in magnetic drug-eluting beads (MDEBs) for targeted cancer therapy.
- Magnetic navigation within MRI scanners offers potential for precise delivery of MDEBs through the vascular system.
Purpose of the Study:
- To develop and validate a method for accurate quantification and localization of MDEBs using MRI.
- To assess the feasibility of magnetically steering MDEBs to specific regions within the body.
Main Methods:
- MDEBs composed of Fe3O4 SPIONs were created and characterized.
- Susceptibility artifacts in 3D VIBE MRI sequences were analyzed in phantoms and swine models.
- A linear volume relationship between MDEB artifacts and MDEB quantity was established.
- Magnetic-injection systems were used for in vivo MDEB steering and embolization.
Main Results:
- A robust linear volume relationship was identified between MDEB artifacts and MDEB quantity, independent of magnetic field orientation and sequence bandwidth.
- The method demonstrated high accuracy (≤ 8.8% error) in quantifying MDEB distribution.
- Successful magnetic steering of MDEBs to desired liver regions was achieved in a swine model.
Conclusions:
- MDEBs can be effectively steered to target locations using magnetic guidance.
- 3D VIBE MRI sequences coupled with artifact analysis provide accurate localization and quantification of MDEB distribution.
- This technique holds promise for image-guided, targeted delivery of cancer therapeutics.

